Trial Profile
European Forsteo Observational Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 26 Jun 2019
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms EFOS
- 22 Apr 2018 Results (n=735) of pooled analysis (subanalysis) of Greek patients from Efos and Exfos studies assessing non-vertebral, clinical vertebral and clinical fracture rates presented at the 2018 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
- 18 Oct 2007 New trial record.